🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open label multicentric randomized phase II trial, using high throughput ge...
Status
Completed
Location
Centre Hospitalier Henri Duffau
Start Date
2014-04-23
Trial ID
NCT02117167
This is a Phase 1 study to assess the safety and clinical activity of RO762...
Status
Completed
Location
University of California Irvine Medical Center
Start Date
2021-08-26
Trial ID
NCT05240898
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of pembroliz...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2016-11-17
Trial ID
NCT02861573
The objective of REVOCAN study is to assess the abrogation of PARP inhibito...
Status
Terminated
Location
CHU Jean Minjoz
Start Date
2020-10-05
Trial ID
NCT04826198
The purpose of this phase I randomised cross over study is to determine and...
Status
Active Not Recruiting
Location
Research Site
Start Date
2008-10-27
Trial ID
NCT00777582
Treatments Being Tested
The study will be conducted in women with advanced (stage IIIa-IV) ovarian ...
Status
Completed
Location
Helse Bergen HF, Haukeland University Hospital
Start Date
2018-05-04
Trial ID
NCT03378297
Treatments Being Tested
This is an efficacy and safety study of olaparib alone or in combination wi...
Status
Completed
Location
Providence Saint Joseph Medical Center, Disney Family Cancer ( Site 1392)
Start Date
2020-08-19
Trial ID
NCT04456699
Treatments Being Tested
The main purpose of this study is to compare the safety and efficacy of PIP...
Status
Unknown
Location
Ruijin Hospital Shanghai Jiaotong University School of Medicine
Start Date
2020-12
Trial ID
NCT04410887
Treatments Being Tested
This is a phase IIB, national, randomized, double-blinded, comparative, mul...
Status
Completed
Location
ICO Paul Papin
Start Date
2019-02-01
Trial ID
NCT03745950
Treatments Being Tested
The main purpose of this study is to explore the feasibility of selecting t...
Status
Recruiting
Location
Tianjin Medical Unversity Second Hospital
Start Date
2024-11-01
Trial ID
NCT06739395